An Integrated Biochemoinformatics System for Drug Discovery
Leming Shi,Zhenqiang Su,Aihua Xie,Chenzhong Liao,Wei Qiao,Dajie Zhang,Song Shan,Desi Pan,Zibin Li,Zhiqiang Ning,Weiming Hu,Xianping Lu
DOI: https://doi.org/10.1007/0-387-25585-0_13
2006-01-01
Abstract:Chipscreen Biosciences, Ltd. (www.chipscreen.com) is a drug discovery company specialized in novel small molecule therapeutics. Chipscreen has developed a proprietary chemical genomics approach to accelerate the discovery of new medicines from its collection of natural products, traditional Chinese medicines, and synthetic chemical libraries. Central to its drug discovery platform is Chipscreen’s capability of integrating in silico drug design, chemical synthesis, unique parallel multi-target high throughput screening, global gene expression profiling, and informatics to rapidly and effectively advance the drug discovery process. To fulfill Chipscreen’s drug discovery needs, we have developed an integrated biochemoinformatics system to efficiently manage and mine various types of experimental data, including chemical structure information, biological activity fingerprints, and gene expression profiling patterns. Well-informed decision on which drug candidates should be advanced into preclinical and clinical development can be made by maximizing the utilities of experimental data stored in the database, thereby lowering the risk and increasing the success rate of the drug discovery and development process.